Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

This study investigated the feasibility of targeting the free, unbound forms of prostate-specific antigen (fPSA) for in vivo imaging of prostate adenocarcinomas (PCa), as PSA is produced and secreted at abundance during every clinical stage and grade of PCa, including castration-resistant disease. W...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Evans-Axelsson, S, Ulmert, D, Örbom, A, Peterson, P, Nilsson, O, Wennerberg, J, Strand, J, Wingårdh, K, Olsson, T, Hagman, Z, Tolmachev, V, Bjartell, A, Lilja, H, Strand, SE
Format:	Journal article
Język:	English
Wydane:	2012

Podobne zapisy

[Isoforms of free prostate-specific antigen]
od: Haese, A, i wsp.
Wydane: (2004)

Isoforms of free prostate-specific antigen
od: Haese, A, i wsp.
Wydane: (2004)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
od: Lilja, H, i wsp.
Wydane: (2008)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
od: Vickers, A, i wsp.
Wydane: (2010)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
od: Vickers, A, i wsp.
Wydane: (2010)

Biology of prostate-specific antigen
od: Lilja, H
Wydane: (2003)

Biology of prostate-specific antigen.
od: Lilja, H
Wydane: (2003)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
od: Sinan Avci, i wsp.
Wydane: (2020-04-01)

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
od: Ulmert, D, i wsp.
Wydane: (2012)

FREE/TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AS PREDICTOR FOR PROSTATE CARCINOMA
od: Sajjad Ahmad, i wsp.
Wydane: (2017-08-01)

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
od: Aus, G, i wsp.
Wydane: (2004)

Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
od: Siivola, P, i wsp.
Wydane: (2000)

Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278))
od: Lilja, H, i wsp.
Wydane: (2008)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
od: Törnblom, M, i wsp.
Wydane: (2001)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
od: Hoon Choi, i wsp.
Wydane: (2013-06-01)

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
od: Lilja, H, i wsp.
Wydane: (2011)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
od: Nouira Yassin, i wsp.
Wydane: (2010-12-01)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
od: Hugosson, J, i wsp.
Wydane: (2003)

Ratios of Free to Total Prostate-Specific Antigen and Total Prostate Specific Antigen to Protein Concentrations in Saliva and Serum of Healthy Men
od: Fahimeh Kamalian, i wsp.
Wydane: (2007-02-01)

Increase in percent free prostate-specific antigen in men with chronic kidney disease.
od: Bruun, L, i wsp.
Wydane: (2009)

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
od: Botchorishvili, G, i wsp.
Wydane: (2009)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
od: Haese, A, i wsp.
Wydane: (2004)

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.
od: Ulmert, D, i wsp.
Wydane: (2006)

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
od: Cao, Y, i wsp.
Wydane: (2002)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
od: Dan Bee Lee, i wsp.
Wydane: (2023-01-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
od: Jeremy YC Teoh, i wsp.
Wydane: (2017-01-01)

Prostatic specific antigen for prostate cancer detection
od: Lucas Nogueira, i wsp.
Wydane: (2009-10-01)

Benign prostatic hyperplasia and prostate-specific antigen
od: Pejčić Tomislav, i wsp.
Wydane: (2015-01-01)

Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.
od: Christensson, A, i wsp.
Wydane: (2010)

Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
od: Olsson, A, i wsp.
Wydane: (2004)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
od: Becker, C, i wsp.
Wydane: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
od: Becker, C, i wsp.
Wydane: (2003)

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
od: Mahyar Ghafoori, i wsp.
Wydane: (2009-08-01)

Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
od: Bruun, L, i wsp.
Wydane: (2003)

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
od: Klein, R, i wsp.
Wydane: (2012)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
od: Steuber, T, i wsp.
Wydane: (2002)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
od: Ahmad Anies Shahab, i wsp.
Wydane: (2013-03-01)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
od: Vickers, A, i wsp.
Wydane: (2011)

Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
od: Olsson, A, i wsp.
Wydane: (2005)

Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening.
od: Savage, C, i wsp.
Wydane: (2010)